She says she went from 60 kg to 49 kg without obesity drugs and credits skipping late meals. MoneyToday ties it to a JAMA Network Open review on timed eating.
Recap by typeshit. Full story at 머니투데이.
The chain says it is exploring concepts including grilled items aimed at GLP-1 users, a sign of how the drugs are shifting food businesses.
Ahead of results, Kalkine looks at how costly late-stage trials for Amgen's monthly obesity shot MariTide weigh on the outlook.
A short post says demand for GLP-1s, psychedelics and testosterone is meeting commercial interests, calling it a big shift.
A beauty take that waves off pricey LA peptide and salmon sperm serums, saying better anti-aging habits are found closer to home.
In Touch Weekly reports the March 2025 death was caused by anaphylaxis and was Australia's first death of its kind linked to anti-aging drugs.
The obesity doctor responds to a pharmacist who claims to expose the truth about GLP-1s. Tap through to see where he agrees and where he pushes back.
Loading…